These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18535407)

  • 1. Molecular and cellular mechanisms of DNA vaccines.
    Coban C; Koyama S; Takeshita F; Akira S; Ishii KJ
    Hum Vaccin; 2008; 4(6):453-6. PubMed ID: 18535407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
    Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
    Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies to improve DNA vaccine immunogenicity.
    Coban C; Kobiyama K; Aoshi T; Takeshita F; Horii T; Akira S; Ishii KJ
    Curr Gene Ther; 2011 Dec; 11(6):479-84. PubMed ID: 22023477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
    Colluru VT; McNeel DG
    Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.
    Allen A; Wang C; Caproni LJ; Sugiyarto G; Harden E; Douglas LR; Duriez PJ; Karbowniczek K; Extance J; Rothwell PJ; Orefo I; Tite JP; Stevenson FK; Ottensmeier CH; Savelyeva N
    Cancer Immunol Immunother; 2018 Apr; 67(4):627-638. PubMed ID: 29330557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
    Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA vaccine].
    Nishikawa H; Shiku H
    Nihon Rinsho; 2008 Oct; 66(10):1867-72. PubMed ID: 18939483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of CpG motifs to the immunogenicity of DNA vaccines.
    Klinman DM; Yamshchikov G; Ishigatsubo Y
    J Immunol; 1997 Apr; 158(8):3635-9. PubMed ID: 9103425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells.
    Dayball K; Millar J; Miller M; Wan YH; Bramson J
    J Immunol; 2003 Oct; 171(7):3379-84. PubMed ID: 14500631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
    Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
    Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
    Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG motifs are efficient adjuvants for DNA cancer vaccines.
    Schneeberger A; Wagner C; Zemann A; Lührs P; Kutil R; Goos M; Stingl G; Wagner SN
    J Invest Dermatol; 2004 Aug; 123(2):371-9. PubMed ID: 15245438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.
    Rush C; Mitchell T; Garside P
    J Immunol; 2002 Nov; 169(9):4951-60. PubMed ID: 12391208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.
    Jin X; Morgan C; Yu X; DeRosa S; Tomaras GD; Montefiori DC; Kublin J; Corey L; Keefer MC;
    Vaccine; 2015 May; 33(20):2347-53. PubMed ID: 25820067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological mechanism of DNA vaccine efficacy].
    Koyama S; Kawagoe T; Akira S; Ishii K
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1096-100. PubMed ID: 21089547
    [No Abstract]   [Full Text] [Related]  

  • 17. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines: a simple DNA sensing matter?
    Coban C; Kobiyama K; Jounai N; Tozuka M; Ishii KJ
    Hum Vaccin Immunother; 2013 Oct; 9(10):2216-21. PubMed ID: 23912600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.
    Riedl P; Reimann J; Schirmbeck R
    J Mol Med (Berl); 2004 Feb; 82(2):144-52. PubMed ID: 14652667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.